Judge Snips DaVita Kickback Claims In FCA Suit

Law360, New York (May 11, 2011, 5:26 PM EDT) -- A Texas federal judge ruled Monday that a former Amgen Inc. employee failed to fully support claims in a qui tam False Claims Act suit accusing dialysis provider DaVita Inc. of receiving kickbacks in the form of educational grants from the drugmaker.

The relator, Ivey Woodard, claimed that DaVita violated the FCA by saying it was in compliance with the anti-kickback statute while it was accepting educational grants from Amgen in exchange for purchasing its blood drug Epogen, or EPO, a drug that stimulates red blood...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

USA, ex rel., vs. Fresenius Medical


Case Number

1:05-cv-00227

Court

Texas Eastern

Nature of Suit

Other Statutory Actions

Judge

Marcia A. Crone

Date Filed

March 21, 2005

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.